Answers are grounded in this paper and cite their sources.
Targeted alpha therapy (TAT) based on 211At represents a highly promising therapeutic strategy for various cancers, yet the rational design of molecular structures remains challenging in practical translation. In this work, we proposed a molecular dynamics (MD) simulation-guided strategy for constructing 124I/211At-labeled aromatic amide derivatives as a potential theranostic pair for melanoma. The interaction process between melanin and a series of aromatic amide derivatives was first investigated via MD simulation, emphasizing that dimethylamino derivatives possessed superior binding ability. Furthermore, radioiodinated dimethylamino derivative [124I]Dm-5-IPLA was proven to have the best tumor-targeting capability and favorable pharmacokinetics via systematic experimental investigations including in vitro cell testing, in vivo PET imaging, and ex vivo biodistribution investigations. Its therapeutic analogue, [211At]Dm-5-APLA, accordingly exhibited effective tumor growth inhibition and satisfactory safety in the TAT of B16F10 tumor-bearing mice, indicating the potential of 124I/211At-labeled aromatic amide derivatives for melanoma theranostics.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: